As of 2025-12-24, the Relative Valuation of Biodesix, Inc. (BDSX) is (64.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.75 USD, the upside of Biodesix, Inc. based on Relative Valuation is -1062.1%.
The range of the Relative Valuation is (56.32) - (76.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 17.5x | 13.8x |
| Forward P/E multiples | 8.5x - 15.4x | 12.4x |
| Fair Price | (56.32) - (76.29) | (64.94) |
| Upside | -934.4% - -1230.2% | -1062.1% |
| Date | P/E |
| 2025-12-23 | -1.36 |
| 2025-12-22 | -1.37 |
| 2025-12-19 | -1.35 |
| 2025-12-18 | -1.43 |
| 2025-12-17 | -1.52 |
| 2025-12-16 | -1.59 |
| 2025-12-15 | -1.51 |
| 2025-12-12 | -1.58 |
| 2025-12-11 | -1.61 |
| 2025-12-10 | -1.64 |
| 2025-12-09 | -1.68 |
| 2025-12-08 | -1.57 |
| 2025-12-05 | -1.55 |
| 2025-12-04 | -1.72 |
| 2025-12-03 | -1.64 |
| 2025-12-02 | -1.58 |
| 2025-12-01 | -1.57 |
| 2025-11-28 | -1.67 |
| 2025-11-26 | -1.58 |
| 2025-11-25 | -1.56 |
| 2025-11-24 | -1.48 |
| 2025-11-21 | -1.38 |
| 2025-11-20 | -1.31 |
| 2025-11-19 | -1.39 |
| 2025-11-18 | -1.45 |
| 2025-11-17 | -1.59 |
| 2025-11-14 | -1.61 |
| 2025-11-13 | -1.59 |
| 2025-11-12 | -1.60 |
| 2025-11-11 | -1.68 |
| 2025-11-10 | -1.52 |
| 2025-11-07 | -1.56 |
| 2025-11-06 | -1.57 |
| 2025-11-05 | -1.73 |
| 2025-11-04 | -1.53 |
| 2025-11-03 | -1.28 |
| 2025-10-31 | -1.38 |
| 2025-10-30 | -1.32 |
| 2025-10-29 | -1.32 |
| 2025-10-28 | -1.32 |
| 2025-10-27 | -1.34 |
| 2025-10-24 | -1.36 |
| 2025-10-23 | -1.29 |
| 2025-10-22 | -1.21 |
| 2025-10-21 | -1.38 |
| 2025-10-20 | -1.33 |
| 2025-10-17 | -1.29 |
| 2025-10-16 | -1.40 |
| 2025-10-15 | -1.49 |
| 2025-10-14 | -1.57 |